178 related articles for article (PubMed ID: 21575637)
1. Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylases.
Kristensen JB; Nielsen AL; Jørgensen L; Kristensen LH; Helgstrand C; Juknaite L; Kristensen JL; Kastrup JS; Clausen RP; Olsen L; Gajhede M
FEBS Lett; 2011 Jun; 585(12):1951-6. PubMed ID: 21575637
[TBL] [Abstract][Full Text] [Related]
2. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
3. Targeting histone lysine demethylases by truncating the histone 3 tail to obtain selective substrate-based inhibitors.
Lohse B; Nielsen AL; Kristensen JB; Helgstrand C; Cloos PA; Olsen L; Gajhede M; Clausen RP; Kristensen JL
Angew Chem Int Ed Engl; 2011 Sep; 50(39):9100-3. PubMed ID: 21919140
[No Abstract] [Full Text] [Related]
4. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
Leurs U; Clausen RP; Kristensen JL; Lohse B
Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
[TBL] [Abstract][Full Text] [Related]
5. Substrate- and cofactor-independent inhibition of histone demethylase KDM4C.
Leurs U; Lohse B; Rand KD; Ming S; Riise ES; Cole PA; Kristensen JL; Clausen RP
ACS Chem Biol; 2014 Sep; 9(9):2131-8. PubMed ID: 25014588
[TBL] [Abstract][Full Text] [Related]
6. A selective inhibitor and probe of the cellular functions of Jumonji C domain-containing histone demethylases.
Luo X; Liu Y; Kubicek S; Myllyharju J; Tumber A; Ng S; Che KH; Podoll J; Heightman TD; Oppermann U; Schreiber SL; Wang X
J Am Chem Soc; 2011 Jun; 133(24):9451-6. PubMed ID: 21585201
[TBL] [Abstract][Full Text] [Related]
7. Compounds and methods for inhibiting histone demethylases: a patent evaluation of US20160102096A1.
Thaler F; Mercurio C
Expert Opin Ther Pat; 2016 Dec; 26(12):1367-1370. PubMed ID: 27730846
[TBL] [Abstract][Full Text] [Related]
8. The future therapeutic potential of histone demethylases: A critical analysis.
Natoli G; Testa G; De Santa F
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
[TBL] [Abstract][Full Text] [Related]
9. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 1. 3-Amino-4-pyridine Carboxylate Derivatives.
Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Diallo H; Douault C; Drewes G; Eagle R; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Liddle J; Mosley J; Muelbaier M; Randle R; Rioja I; Rueger A; Seal GA; Sheppard RJ; Singh O; Taylor J; Thomas P; Thomson D; Wilson DM; Lee K; Prinjha RK
J Med Chem; 2016 Feb; 59(4):1357-69. PubMed ID: 26771107
[TBL] [Abstract][Full Text] [Related]
10. A new horizon for epigenetic medicine?
Chen S; Shi Y
Cell Res; 2013 Mar; 23(3):326-8. PubMed ID: 22986503
[TBL] [Abstract][Full Text] [Related]
11. Identification of non-histone substrates for JMJD2A-C histone demethylases.
Ponnaluri VK; Vavilala DT; Putty S; Gutheil WG; Mukherji M
Biochem Biophys Res Commun; 2009 Dec; 390(2):280-4. PubMed ID: 19799855
[TBL] [Abstract][Full Text] [Related]
12. Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.
Westaway SM; Preston AG; Barker MD; Brown F; Brown JA; Campbell M; Chung CW; Drewes G; Eagle R; Garton N; Gordon L; Haslam C; Hayhow TG; Humphreys PG; Joberty G; Katso R; Kruidenier L; Leveridge M; Pemberton M; Rioja I; Seal GA; Shipley T; Singh O; Suckling CJ; Taylor J; Thomas P; Wilson DM; Lee K; Prinjha RK
J Med Chem; 2016 Feb; 59(4):1370-87. PubMed ID: 26771203
[TBL] [Abstract][Full Text] [Related]
13. Studies on substrate specificity of Jmjd2a-c histone demethylases.
Ponnaluri VK; Vavilala DT; Mukherji M
Biochem Biophys Res Commun; 2011 Feb; 405(4):588-92. PubMed ID: 21266164
[TBL] [Abstract][Full Text] [Related]
14. Lysine demethylases inhibitors.
Suzuki T; Miyata N
J Med Chem; 2011 Dec; 54(24):8236-50. PubMed ID: 21955276
[No Abstract] [Full Text] [Related]
15. Structural definitions of Jumonji family demethylase selectivity.
Pilka ES; James T; Lisztwan JH
Drug Discov Today; 2015 Jun; 20(6):743-9. PubMed ID: 25555749
[TBL] [Abstract][Full Text] [Related]
16. Identification of catechols as histone-lysine demethylase inhibitors.
Nielsen AL; Kristensen LH; Stephansen KB; Kristensen JB; Helgstrand C; Lees M; Cloos P; Helin K; Gajhede M; Olsen L
FEBS Lett; 2012 Apr; 586(8):1190-4. PubMed ID: 22575654
[TBL] [Abstract][Full Text] [Related]
17. KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.
Boila LD; Chatterjee SS; Banerjee D; Sengupta A
Exp Hematol; 2018 Feb; 58():44-51.e7. PubMed ID: 29111428
[TBL] [Abstract][Full Text] [Related]
18. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway.
Jiang W; Wang J; Zhang Y
Cell Res; 2013 Jan; 23(1):122-30. PubMed ID: 22907667
[TBL] [Abstract][Full Text] [Related]
19. The KDM5 family of histone demethylases as targets in oncology drug discovery.
Rasmussen PB; Staller P
Epigenomics; 2014 Jun; 6(3):277-86. PubMed ID: 25111482
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors.
Labadie SS; Dragovich PS; Cummings RT; Deshmukh G; Gustafson A; Han N; Harmange JC; Kiefer JR; Li Y; Liang J; Liederer BM; Liu Y; Manieri W; Mao W; Murray L; Ortwine DF; Trojer P; VanderPorten E; Vinogradova M; Wen L
Bioorg Med Chem Lett; 2016 Sep; 26(18):4492-4496. PubMed ID: 27499454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
